Market cap
$36,150 Mln
Revenue (TTM)
$254,425 Mln
P/E Ratio
21.9
P/B Ratio
5.6
Div. Yield
1.1 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$1,689 Mln
-
ROE
2.3 %
-
ROCE
27.6 %
-
Industry P/E
50.52
-
EV/EBITDA
11.4
-
Debt to Equity
4.5
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
200,854,000
10 Years Aggregate
CFO
$22,171.29 Mln
EBITDA
$22,659.39 Mln
Net Profit
$4,770.68 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
AmerisourceBergen (ABC)
| 8.6 | -0.2 | -5.1 | 30.0 | 22.6 | 14.3 | 11.4 |
|
BSE Sensex*
| -9.6 | 1.8 | 2.7 | -5.6 | 6.8 | 7.7 | 11.1 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
AmerisourceBergen (ABC)
| 24.7 | 38.0 | 17.0 | 16.5 | -17.5 | 19.5 | -23.3 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
AmerisourceBergen (ABC)
|
180.0 | 36,149.7 | 254,425.2 | 1,689.5 | 1.0 | 355.8 | 21.9 | 5.6 |
| 88.7 | 153,593.1 | 45,134.0 | 6,276.0 | 15.4 | 12.2 | 24.7 | 3.0 | |
| 46.8 | 70,111.4 | 20,615.0 | 3,553.0 | 19.9 | 14.5 | 19.7 | 2.8 | |
| 181.1 | 127,957.8 | 24,778.0 | 3,689.0 | 18.5 | 7.1 | 35.1 | 2.4 | |
| 86.3 | 49,006.3 | 6,303.5 | 1,092.8 | 12.7 | 10.6 | 46 | 4.8 | |
| 570.0 | 44,243.9 | 4,446.1 | 1,095.2 | 31.7 | 70.3 | 41.3 | 28.4 | |
| 416.6 | 145,582.2 | 10,582.1 | 2,979.1 | 25.0 | 17.2 | 50 | 8.3 | |
| 80.4 | 103,134.5 | 36,364.0 | 4,800.0 | 13.3 | 19.6 | 21.5 | 2.1 | |
| 307.9 | 117,170.4 | 25,270.0 | 3,337.0 | 18.7 | 15.1 | 35.3 | 5.1 | |
| 473.7 | 176,765.5 | 45,197.0 | 6,859.0 | 19.2 | 13.3 | 26.2 | 3.4 |
Shareholding Pattern
View DetailsAbout AmerisourceBergen (ABC)
AmerisourceBergen Corporation sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and... related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to customers in the companion animal and production animal markets, as well as demand-creating sales force services to manufacturer. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segments also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania. Read more
-
Chairman, Pres & CEO
Mr. Steven H. Collis
-
Exec. VP & CFO
Mr. James F. Cleary Jr.
-
Headquarters
Conshohocken, PA
-
Website
FAQs for AmerisourceBergen (ABC)
What is the current share price of AmerisourceBergen (ABC) Today?
The share price of AmerisourceBergen (ABC) is $179.97 (NYSE) as of 29-Sep-2023 09:30 EDT. AmerisourceBergen (ABC) has given a return of 22.63% in the last 3 years.
What is the current PB & PE ratio of AmerisourceBergen (ABC)?
The P/E ratio of AmerisourceBergen (ABC) is 21.92 times as on 29-Sep-2023, a 57 discount to its peers’ median range of 50.52 times.
The P/B ratio of AmerisourceBergen (ABC) is 5.58 times as on 29-Sep-2023, a 66 premium to its peers’ median range of 3.37 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
--
|
--
|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
What is the 52 Week High and Low of AmerisourceBergen (ABC)?
The 52-week high and low of AmerisourceBergen (ABC) are Rs -- and Rs -- as of 16-Jun-2026.
What is the market cap of AmerisourceBergen (ABC)?
AmerisourceBergen (ABC) has a market capitalisation of $ 36,150 Mln as on 29-Sep-2023. As per SEBI classification, it is a company.
Should I invest in AmerisourceBergen (ABC)?
Before investing in AmerisourceBergen (ABC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.